Kainos Laboratories, Inc. (4556) Stock Statistics & Valuation Metrics

Kainos Laboratories, Inc. has a market cap or net worth of ¥9.28B. The enterprise value is ¥2.52B.

Kainos Laboratories, Inc. has 4,558,860 shares outstanding. The number of shares has decreased by -2.65% in one year.

Kainos Laboratories, Inc.’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 8.51%.

The current PE Ratio of Kainos Laboratories, Inc. is 9.5. Kainos Laboratories, Inc.’s PEG ratio is -62.73.

In the last 12 months, Kainos Laboratories, Inc. had revenue of 5.31B and earned 641.02M in profits. Earnings per share was 152.06.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Kainos Laboratories, Inc. pays an annual dividend of ¥32, resulting in a dividend yield of 2.53%

Kainos Laboratories, Inc. upcoming earnings date is May 8, 2026, TBA (Confirmed).

Kainos Laboratories, Inc. as a current ratio of 4.00, with Debt / Equity ratio of ―

In the past 12 months, Kainos Laboratories, Inc. has paid 186.13M in taxes.

Kainos Laboratories, Inc. EV to EBITDA ratio is 2.74, with an EV/FCF ratio of 3.97.

Kainos Laboratories, Inc. has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of 15.52%, and net profit margin of 12.08%.

The average price target for Kainos Laboratories, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―